Pharma & Biotech

The investment narrative surrounding Denali Therapeutics presents a fascinating paradox. While its pipeline of therapies for neurodegenerative diseases generates significant...

Biopharmaceutical company NuCana faces a period of significant catalysts and challenges. With crucial clinical data on the horizon and a...

While Twist Bioscience delivered exceptional third-quarter financial results, its shares continue to face significant pressure from both legal proceedings and...

Bayer AG faces renewed pressure as a highly anticipated cardiovascular drug candidate failed to meet its primary endpoint in critical...

The corporate structure of Walgreens has undergone a fundamental transformation with the completion of its acquisition by private equity firm...

Claritev, a prominent healthcare technology firm, took center stage this week with a dual-pronged communications effort aimed at the investment...

Shares of Abeona Therapeutics advanced 1.46% to $6.95 in the previous session as investor focus sharpened on the company's upcoming...

A notable institutional investor has established a new position in Viking Therapeutics, providing fresh momentum for the biopharmaceutical stock. This...

The acquisition of Inozyme Pharma Inc by BioMarin Pharmaceutical was formally completed in July, marking a significant consolidation in the...

Despite completing its transition to private ownership in October 2024, PetIQ finds itself navigating significant legal challenges. The animal health...